The expression levels of LIMA1 in liver tissue and serum sEV of clinical NAFLD patients are still unknown, and further investigation is needed to understand the relationship between LIMA1 and the progression of clinical liver fibrosis. Here, LIMA1 is linked to metabolic dysfunction-associated steatotic liver disease.